|
SMC5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.720830E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.223800E-01 |
| Normal-vs-Stage2 |
6.304600E-01 |
| Normal-vs-Stage3 |
1.721820E-01 |
| Normal-vs-Stage4 |
9.074200E-01 |
| Stage1-vs-Stage2 |
9.338200E-01 |
| Stage1-vs-Stage3 |
6.910300E-02 |
| Stage1-vs-Stage4 |
6.286600E-01 |
| Stage2-vs-Stage3 |
2.499400E-01 |
| Stage2-vs-Stage4 |
6.325600E-01 |
| Stage3-vs-Stage4 |
4.258600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.037200E-01 |
| Normal-vs-AfricanAmerican |
2.360800E-01 |
| Normal-vs-Asian |
1.189630E-01 |
| Caucasian-vs-AfricanAmerican |
6.445800E-01 |
| Caucasian-vs-Asian |
2.565200E-01 |
| AfricanAmerican-vs-Asian |
1.960590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.024600E-01 |
| Normal-vs-Female |
1.283000E-01 |
| Male-vs-Female |
3.444400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.256200E-01 |
| Normal-vs-Extreme_Weight |
7.100400E-01 |
| Normal-vs-Obese |
1.306840E-01 |
| Normal-vs-Extreme_Obese |
9.988000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.302800E-01 |
| Normal_Weight-vs-Obese |
2.072600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.622800E-01 |
| Extreme_Weight-vs-Obese |
2.404200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.716400E-01 |
| Obese-vs-Extreme_Obese |
4.902000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.206400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.829700E-02 |
| Normal-vs-Age(61-80Yrs) |
7.557800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.796800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.863000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.960600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.203000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.216100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.076980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.781000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.415300E-03 |
| Normal-VS-Type2 PRCC |
3.020500E-03 |
| Normal-VS-KIRP CIMP |
3.911800E-01 |
| Normal-VS-Unclassified PRCC |
5.483200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.85590020918403E-10 |
| Type1 PRCC-VS-KIRP CIMP |
8.687400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.652970E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.304440E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.498200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.294800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.986300E-02 |
| Normal-vs-N1 |
4.463600E-01 |
| Normal-vs-N2 |
3.623200E-01 |
| N0-vs-N1 |
9.265700E-02 |
| N0-vs-N2 |
9.617000E-01 |
| N1-vs-N2 |
4.842600E-01 |
|
|
